Cargando…
PB01 suppresses radio-resistance by regulating ATR signaling in human non-small-cell lung cancer cells
Despite the common usage of radiotherapy for the treatment of human non-small-cell lung cancer (NSCLC), cancer therapeutic efficacy and outcome with ionizing radiation remains a challenge. Here, we report the antitumor effects and mechanism of a novel benzothiazole derivative PB01 (4-methoxy-cyclohe...
Autores principales: | Kim, Tae Woo, Hong, Da-Won, Hong, Sung Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187425/ https://www.ncbi.nlm.nih.gov/pubmed/34103635 http://dx.doi.org/10.1038/s41598-021-91716-z |
Ejemplares similares
-
CB11, a novel purine-based PPARɣ ligand, overcomes radio-resistance by regulating ATM signalling and EMT in human non-small-cell lung cancer cells
por: Kim, Tae Woo, et al.
Publicado: (2020) -
CB13, a novel PPARγ ligand, overcomes radio-resistance via ROS generation and ER stress in human non-small cell lung cancer
por: Kim, Tae Woo, et al.
Publicado: (2020) -
A novel PPARɣ ligand, PPZ023, overcomes radioresistance via ER stress and cell death in human non-small-cell lung cancer cells
por: Kim, Tae Woo, et al.
Publicado: (2020) -
ATR inhibition augments the efficacy of lurbinectedin in small‐cell lung cancer
por: Schultz, Christopher W, et al.
Publicado: (2023) -
The ATR inhibitor berzosertib acts as a radio- and chemosensitizer in head and neck squamous cell carcinoma cell lines
por: Schnoell, Julia, et al.
Publicado: (2023)